Human neuropharmacology studies are focused in identifying the pathways and different biochemical markers for exploitation as targets for modulation of these pathways’ irregularities with xenobiotics and biotics variables. A successful goal pursuit of neurodegenerative populations can result in good health, scholastic and professional performance, financial well-being, and healthy interpersonal ties. Many people fail to achieve even the common objectives in neuropharmacology. Successful compound/ligand translation into drug-like compounds requires an understanding of the factors that help or hinder neurodegenerative studies. This topic has received huge traction across social and cognitive pharmacists, clinicians, the pharmaceutical industry, as well as other health practitioners and associated professionals.
Though neuro-degeneration research in geriatrics has made substantial progress in recent decades, scientists are particularly interested in the development of innovative and effective therapies for a variety of neurological disorders. This includes the role of important parameters in disease progression. Due to invisibility in scientific areas, several research areas with potential profiles for emancipating disease pathways are being investigated. Successful compound/ligand translation into drug-like molecules or studying of alternate illness therapy routes require an understanding of the factors that help or impede disease progression research. Despite, the medical community and the pharmaceutical business paying more attention to this topic in recent years, as well as research progressing tremendously, there are still many unsolved concerns. The purpose of this Research Topic is to give researchers a place to share their most recent findings on neurodegenerative disorders pathway profiling.
We open by presenting an outline of the current state of neuronal research. This research focuses on disease behavior with acute/chronic profile along with the pediatric and geriatrics pattern, multifocality constraint, and imbalance because of in-silico/in-vivo/in-vitro and systematic compound/ligand research in neural degenerative research. It is advantageous to have a "proper mix" of multiple orientations in terms of behavior and chemical modifications. While we participate in isolation, characterization, synthesis, enzymatic and non-enzymatic research, understanding these and other factors, such as the participation of biomarkers and neurotransmitters can lead to comparable long-term goal engagement and management in the future (molecular and behavioral level preclinical studies). Recording and analyzing the extent of overexpression and downregulation of biomarkers, neurotransmitters, and proteins, all of which are undesirable outcomes, is another crucial component of research.
Original Manuscripts, Review Articles, Commentaries, Communication Letters and Mini Reviews focusing on, but not limited to, any of the following themes are warmly welcome in this Research Topic:
• Neurodegenerative studies of natural/synthetic compounds
• Pathways leading to neurodegeneration
• Animal models for the neurodegenerative studies
• Molecular- and cellular-level toxicity studies of neurodegeneration
• Natural products and their Neuro protective functions
• Short- and long-duration studies involving neuronal mechanism of Alzheimer’s etc
• Protective role of antioxidants against neurodegenerative disease
Human neuropharmacology studies are focused in identifying the pathways and different biochemical markers for exploitation as targets for modulation of these pathways’ irregularities with xenobiotics and biotics variables. A successful goal pursuit of neurodegenerative populations can result in good health, scholastic and professional performance, financial well-being, and healthy interpersonal ties. Many people fail to achieve even the common objectives in neuropharmacology. Successful compound/ligand translation into drug-like compounds requires an understanding of the factors that help or hinder neurodegenerative studies. This topic has received huge traction across social and cognitive pharmacists, clinicians, the pharmaceutical industry, as well as other health practitioners and associated professionals.
Though neuro-degeneration research in geriatrics has made substantial progress in recent decades, scientists are particularly interested in the development of innovative and effective therapies for a variety of neurological disorders. This includes the role of important parameters in disease progression. Due to invisibility in scientific areas, several research areas with potential profiles for emancipating disease pathways are being investigated. Successful compound/ligand translation into drug-like molecules or studying of alternate illness therapy routes require an understanding of the factors that help or impede disease progression research. Despite, the medical community and the pharmaceutical business paying more attention to this topic in recent years, as well as research progressing tremendously, there are still many unsolved concerns. The purpose of this Research Topic is to give researchers a place to share their most recent findings on neurodegenerative disorders pathway profiling.
We open by presenting an outline of the current state of neuronal research. This research focuses on disease behavior with acute/chronic profile along with the pediatric and geriatrics pattern, multifocality constraint, and imbalance because of in-silico/in-vivo/in-vitro and systematic compound/ligand research in neural degenerative research. It is advantageous to have a "proper mix" of multiple orientations in terms of behavior and chemical modifications. While we participate in isolation, characterization, synthesis, enzymatic and non-enzymatic research, understanding these and other factors, such as the participation of biomarkers and neurotransmitters can lead to comparable long-term goal engagement and management in the future (molecular and behavioral level preclinical studies). Recording and analyzing the extent of overexpression and downregulation of biomarkers, neurotransmitters, and proteins, all of which are undesirable outcomes, is another crucial component of research.
Original Manuscripts, Review Articles, Commentaries, Communication Letters and Mini Reviews focusing on, but not limited to, any of the following themes are warmly welcome in this Research Topic:
• Neurodegenerative studies of natural/synthetic compounds
• Pathways leading to neurodegeneration
• Animal models for the neurodegenerative studies
• Molecular- and cellular-level toxicity studies of neurodegeneration
• Natural products and their Neuro protective functions
• Short- and long-duration studies involving neuronal mechanism of Alzheimer’s etc
• Protective role of antioxidants against neurodegenerative disease
